Sage Journals: Discover world-class research

Retricted access

Other

First published 2006-12

Sample Size Reestimation: A Review and Recommendations

Christy Chuang-Stein, Keaven Anderson, Paul Gallo [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Other

First published 2003-7

An Example of an Unblinded,Third-Party Interim Analysis for Sample Size Re-Estimation

Simon Kirby, Scott McBride, Lohita Puvanarajan

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2018-8

Adjusting for bias in unblinded randomized controlled trials

AF Schmidt, RHH Groenwold

Statistical Methods in Medical Research

Free access

First published 2000-12

Radiological review of interval cancers in an Australian mammographic screening programme

Journal of Medical Screening

Retricted access

Research article

First published 2024

Is inadequate risk stratification diluting hazard ratio estimates in randomized clinical trials?

Devan V Mehrotra, Rachel Marceau West

Clinical Trials

Retricted access

Research article

First published 2014-4

Statistical Analysis Plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) Trial

Philip M. W. Bath, Aimee Houlton, Lisa Woodhouse [...]

International Journal of Stroke

Free access

Research article

First published 2010-11

Epilepsy Treatment Stimulus Package? Deep Brain Stimulation in Treatment-Resistant Focal Epilepsy

Chad Carlson

Epilepsy Currents

Open access

Research article

First published 2020-6

Outcome assessment by central adjudicators in randomised stroke trials: Simulation of differential and non-differential misclassification

Peter J Godolphin, Philip M Bath, Christopher Partlett [...]

European Stroke Journal

Open access

Research article

First published 2023-6

Using modified intention-to-treat as a principal stratum estimator for failure to initiate treatment

Brennan C Kahan, Ian R White, Mark Edwards [...]

Clinical Trials

Retricted access

Research article

First published 2024-03

A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70–180 mg/dL Versus Time-in-Tight-Range 70–140 mg/dL

Roy W. Beck, Dan Raghinaru, Peter Calhoun [...]

Diabetes Technology & Therapeutics

Search results